KindlyMD, Inc. secures shareholder approval for its proposed merger with Nakamoto Holdings Inc., marking a major step toward becoming one of the biggest Bitcoin treasury companies on the market.

The majority of KindlyMD’s shareholders delivered written consent in favor of the merger on May 18, 2025. The transaction is now on track to close in the third quarter of 2025, following the SEC’s review and distribution of an information statement to shareholders.

KindlyMD, Inc. (Nasdaq: KMDH) has obtained shareholder approval for its proposed merger with Nakamoto Holdings Inc. The majority of KindlyMD’s shareholders delivered written consent in favor of the merger on May 18, 2025.

The transaction is now expected to close in the third quarter of 2025, following the U.S. Securities and Exchange Commission’s (SEC) review and distribution of an information statement to shareholders.

Under current terms, the deal will close 20 days after the statement is mailed.

The merger agreement was previously announced on March 10, 2025, and the parties had been working to obtain the necessary shareholder and regulatory approvals for the transaction to proceed.

Upon closing of the merger, KindlyMD will become one of the largest Bitcoin treasury companies in the public markets. The combined company will be named Nakamoto and will trade on the Nasdaq Stock Market under the ticker symbol “NMTO.”

KindlyMD is a unique healthcare company that integrates cutting-edge technology and data to deliver superior clinical and economic outcomes.

The company’s programs are designed to reduce opioid dependence, improve patient satisfaction, and provide patients with personalized treatment options.

KindlyMD’s clinical services are reimbursed through Medicare, Medicaid, and commercial insurance.

Nakamoto is a new holding company that is focused on acquiring and integrating a portfolio of companies with a shared vision for Bitcoin’s role in the future of finance and commerce.

The company’s mission is to create a global ecosystem of Bitcoin companies that are leaders in their respective industries.

“This milestone brings us one step closer to unlocking Bitcoin’s potential for KindlyMD shareholders,” said David Bailey, Founder and CEO of Nakamoto. “We are grateful that KindlyMD shares our vision for a future in which Bitcoin is a core part of the corporate balance sheet, and investors across global capital markets have exposure to the world’s greatest asset and store of value.”

Nakamoto is building a global portfolio of companies aligned around Bitcoin’s core principles. Through treasury strategy and targeted acquisitions, the company aims to redefine capital markets infrastructure with Bitcoin at the center.

KindlyMD, meanwhile, brings to the table a unique model of integrated, data-driven healthcare focused on reducing opioid dependence and improving outcomes through personalized treatment and alternative medicine education. Its clinical services are reimbursed through Medicare, Medicaid, and commercial insurance.

Here is the full statement from KindlyMD:

KindlyMD, Inc. (Nasdaq: KMDH) today announced that it has obtained the requisite shareholder approval for its proposed merger with Nakamoto Holdings Inc. The majority of KindlyMD’s shareholders have delivered written consent in favor of the merger.

The transaction is now expected to close in the third quarter of 2025, following the U.S. Securities and Exchange Commission’s (SEC) review and distribution of an information statement to shareholders.

Under current terms, the deal will close 20 days after the statement is mailed.

The merger agreement was previously announced on March 10, 2025, and the parties have been working to obtain the necessary shareholder and regulatory approvals for the transaction to proceed.

Upon closing of the merger, KindlyMD will become one of the largest Bitcoin treasury companies in the public markets. The combined company will be named Nakamoto and will trade on the Nasdaq Stock Market under the ticker symbol “NMTO.”

KindlyMD is a unique healthcare company that integrates cutting-edge technology and data to deliver superior clinical and economic outcomes.

The company’s programs are designed to reduce opioid dependence, improve patient satisfaction, and provide patients with personalized treatment options.

KindlyMD’s clinical services are reimbursed through Medicare, Medicaid, and commercial insurance.

Nakamoto is a new holding company that is focused on acquiring and integrating a portfolio of companies with a shared vision for Bitcoin’s role in the future of finance and commerce.

The company’s mission is to create a global ecosystem of Bitcoin treasury companies that are leaders in their respective industries.

“We are pleased to achieve this important milestone in the merger process,” said Tim Pickett, CEO of KindlyMD.

“As a combined company, we are excited to leverage Bitcoin’s dominance and real-world utility to strengthen our company and drive sustained long-term value for our investors.”

“This milestone brings us one step closer to unlocking Bitcoin’s potential for KindlyMD shareholders,” added David Bailey, Founder and CEO of Nakamoto.

“We are grateful that KindlyMD shares our vision for a future in which Bitcoin is a core part of the corporate balance sheet, and investors across global capital markets have exposure to the world’s greatest asset and store of value.”